Miller D S, Nobmann S N, Gutmann H, Toeroek M, Drewe J, Fricker G
Laboratory of Pharmacology and Chemistry, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina 27709, USA.
Mol Pharmacol. 2000 Dec;58(6):1357-67. doi: 10.1124/mol.58.6.1357.
To identify specific transporters that drive xenobiotics from central nervous system to blood, the accumulation of fluorescent drugs was studied in isolated capillaries from rat and pig brain using confocal microscopy and quantitative image analysis. Luminal accumulation of daunomycin and of fluorescent derivatives of cyclosporine A (CSA) and ivermectin was concentrative, specific, and energy-dependent (inhibition by NaCN). Transport was reduced by PSC 833, ivermectin, verapamil, CSA, and vanadate, but not by leukotriene C(4) (LTC(4)), indicating the involvement of P-glycoprotein. Luminal accumulation of the fluorescent organic anions sulforhodamine 101 and fluorescein methotrexate was also concentrative, specific, and energy-dependent. LTC(4), chlorodinitrobenzene, and vanadate reduced transport of these compounds, but PSC 833 and verapamil did not, indicating the involvement of a multidrug resistance-associated protein (Mrp). Immunostaining localized P-glycoprotein and Mrp2 to the luminal surface of the capillary endothelium and quantitative polymerase chain reaction showed Mrp1 and Mrp2 expression. Finally, the HIV protease inhibitors saquinavir and ritonavir were potent inhibitors of transport mediated by both P-glycoprotein and Mrp. These results validate a new method for studying drug transport in isolated brain capillaries and implicate both P-glycoprotein and one or more members of the Mrp family in drug transport from central nervous system to blood.
为了确定将外源性物质从中枢神经系统转运至血液的特定转运体,利用共聚焦显微镜和定量图像分析技术,研究了荧光药物在大鼠和猪脑分离毛细血管中的蓄积情况。柔红霉素、环孢素A(CSA)荧光衍生物和伊维菌素在管腔中的蓄积具有浓缩性、特异性且依赖能量(被NaCN抑制)。PSC 833、伊维菌素、维拉帕米、CSA和钒酸盐可降低转运,但白三烯C4(LTC4)则无此作用,这表明P-糖蛋白参与其中。荧光有机阴离子磺罗丹明101和荧光甲氨蝶呤在管腔中的蓄积同样具有浓缩性、特异性且依赖能量。LTC4、氯二硝基苯和钒酸盐可降低这些化合物的转运,但PSC 833和维拉帕米则无此作用,这表明多药耐药相关蛋白(Mrp)参与其中。免疫染色将P-糖蛋白和Mrp2定位至毛细血管内皮的管腔表面,定量聚合酶链反应显示有Mrp1和Mrp2表达。最后,HIV蛋白酶抑制剂沙奎那韦和利托那韦是P-糖蛋白和Mrp介导转运的有效抑制剂。这些结果验证了一种研究分离脑毛细血管中药物转运的新方法,并表明P-糖蛋白和Mrp家族的一个或多个成员参与了药物从中枢神经系统至血液的转运。